Milestone 1 Award-Winning Team in XPRIZE Healthspan $101 Million Competition
Team - A New Dimension - led by BlueOakNx co-founder
BlueOakNx announces the selection of a team led by BlueOakNx co-founder Dr. Sundeep Dugar, to be a semifinalist and Top 40 Milestone 1 Award winning team in the prestigious XPRIZE Healthspan competition.
The team – under the name A New Dimension – was one of 40 teams selected from 600+ pre-registered teams from 60 countries.
The team includes eminent scientists and clinicians including Prof. Paul Shiels (University of Glasgow), Prof. Peter Stenvinkel (Karolinska University Hospital), Prof. Richard Johnson (University of Colorado), and Paul Maffuid. The team’s expertise spans across successful drug discovery, pre-clinical development, clinical development, drug approval, and the launch of a practitioner-grade dietary supplement.
About XPRIZE Healthspan
Increasing human life expectancy is one of the greatest breakthroughs in modern history. We have more than doubled the global average in the last 100 years, but the length of our healthy lives has not increased at the same rate.
XPRIZE Healthspan is a 7-year, $101 million global competition to revolutionize the way we approach human aging. Competing teams will develop and test therapeutics that restore muscle, cognition, and immune function by a minimum of 10 years with a goal of 20 years.
Teams were evaluated based on the best, most feasible, and safe approaches. The top 100 Teams are all considered Semifinalists, and presented a single or combination therapeutic approach that demonstrates feasibility to restore muscle, brain, and immune function lost to age-related degradation by at least 10 years, with an ambitious goal of 20 years, and deliver their therapy in 1-year or less in adults aged 50-80 years who are free of major or life-threatening disease and disability.
Top 40 Milestone 1 Award-winning teams are each receiving $250,000 to help support them through the next phase of the competition.
Read the XPRIZE Healthspan press release.
About XPRIZE
XPRIZE is the recognized global leader in designing and executing large-scale competitions to solve humanity’s greatest challenges. For 30 years, our unique model has democratized crowd-sourced innovation and scientifically scalable solutions that accelerate a more equitable and abundant future. Donate, learn more, and co-architect a world of abundance with us at XPRIZE.org.
About BlueOakNx
BlueOakNx is a Public Benefit Corporation on a mission to provide affordable access to science-based, practitioner-grade nutraceuticals that enable a better quality of life from the inside out.
The company’s first product Mitokatlyst™ – E is backed by 15 clinical studies, 45 years of combined research by Blue Oak scientists, and 64 peer-reviewed papers. Mitokatlyst™ is the first targeted molecule clinically proven to induce mitochondrial biogenesis and boost cellular energy. This promotes skeletal muscle strength, supports metabolic function, supports cardiovascular health, and stimulates a healthy inflammatory response.
The product was introduced in August 2024; since then, new clinical trials and observational studies have been initiated, or are in process, at various universities in the US and Sweden.
Read about the role of mitochondria in healthspan, longevity and wellness
